Observational Study of the Interaction Between Hepatitis C Virus Infection and Pregnancy
NCT05929963 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-07-05
Summary
The goal of this observational study is to learn about he effects of hepatitis C virus on pregnancy. The main question\[s\] it aims to answer are:
Effect of hepatitis C virus on liver function in pregnant women Mother-to-child transmission rate in pregnant women with hepatitis C
Conditions
- Hepacivirus
- Pregnancy
Interventions
- OTHER
-
HCV infection status
Divided into 3 groups based on HCVAb and HCVRNA status
Sponsors & Collaborators
-
Beijing Ditan Hospital
lead OTHER
Principal Investigators
-
Yao Xie, Doctor · Beijing Ditan Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-05-09
- Primary Completion
- 2024-02-20
- Completion
- 2025-01-01
Countries
- China
Study Locations
More Related Trials
-
Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens
NCT03366610 ·Status: COMPLETED
-
HCV (Hepatitis C Virus) Viral and Host Genotyping (IL28B, Interleukin 28B) in China
NCT01293279 ·Status: COMPLETED
-
A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.
NCT01594554 ·Status: UNKNOWN
-
Observational Study in HCV Chronic Infection
NCT01945008 ·Status: COMPLETED
-
Immune Response to Hepatitis C Virus
NCT00006301 ·Status: COMPLETED
-
The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
NCT01289652 ·Status: UNKNOWN
-
Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress System
NCT06508996 ·Status: COMPLETED
-
Impact of Interferon-free Treatment for Hepatitis C Virus (HCV) on Blood Cells and Factors in Blood
NCT02718573 ·Status: COMPLETED
-
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
NCT00735969 ·Status: COMPLETED ·Phase: PHASE2
-
Transmission of Chronic Hepatitis C in Pregnancy
NCT03570112 ·Status: COMPLETED
-
Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3
NCT00056862 ·Status: COMPLETED ·Phase: PHASE4
-
Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis C
NCT00980161 ·Status: UNKNOWN
-
Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)
NCT00423670 ·Status: COMPLETED ·Phase: PHASE2
-
Qualification of Point-of-Care Assays for Management of HCV Patients
NCT02335320 ·Status: UNKNOWN
-
Study to Assess the Efficacy of 12 Versus 24 Weeks of Extended Treatment in HCV-Genotype 2/3 Patients
NCT00803309 ·Status: TERMINATED ·Phase: PHASE4
-
Early Prediction of Successful Treatment for Chronic Hepatitis C Virus Infection in Taiwan
NCT00543244 ·Status: UNKNOWN
-
Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection
NCT03235349 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1
NCT02629172 ·Status: COMPLETED
-
A Phase 3 Evaluation of Daclatasvir and Asunaprevir in Treatment-naive Subjects With Chronic Hepatitis C Genotype 1b Infection
NCT02496078 ·Status: COMPLETED ·Phase: PHASE3
-
Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting
NCT00222859 ·Status: COMPLETED
-
Pegylated Interferon Therapy for Acute Hepatitis C Infection in HIV-infected Patients
NCT00132210 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)
NCT00709228 ·Status: COMPLETED
-
Hepatitis C: Grading and Staging by MR
NCT00059397 ·Status: COMPLETED
-
Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
NCT00759200 ·Status: COMPLETED ·Phase: PHASE2
-
Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine
NCT00310336 ·Status: COMPLETED ·Phase: PHASE2/PHASE3